7 Related NICE guidance
Published
-
Natalizumab for the treatment of adults with highly active relapsing–remitting multiple sclerosis. NICE technology appraisal guidance 127 (2007).
-
Multiple sclerosis: management of multiple sclerosis in primary and secondary care. NICE clinical guideline 8 (2003).
-
Beta interferon and glatiramer acetate for the treatment of multiple sclerosis. NICE technology appraisal guidance 32 (2002).